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ABSTRACT: Introduction: The purpose of this study was to
develop an evidence-based guideline for the use of neuromus-
cular ultrasound in the diagnosis of carpal tunnel syndrome
(CTS). Methods: Two questions were asked: (1) What is the ac-
curacy of median nerve cross-sectional area enlargement as
measured with ultrasound for the diagnosis of CTS? (2) What
added value, if any, does neuromuscular ultrasound provide
over electrodiagnostic studies alone for the diagnosis of CTS?
A systematic review was performed, and studies were classified
according to American Academy of Neurology criteria for rating
articles of diagnostic accuracy (question 1) and for screening
articles (question 2). Results: Neuromuscular ultrasound mea-
surement of median nerve cross-sectional area at the wrist is
accurate and may be offered as a diagnostic test for CTS
(Level A). Neuromuscular ultrasound probably adds value to
electrodiagnostic studies when diagnosing CTS and should be
considered in screening for structural abnormalities at the wrist
in those with CTS (Level B).
Muscle Nerve 46: 287–293, 2012
Carpal tunnel syndrome (CTS) is a combination
of signs and symptoms resulting from mononeurop-
athy of the median nerve as it passes through the
rigid carpal tunnel in the wrist.1 It is a common con-
dition that affects 2.7% of the general population
and results in health-care costs exceeding $500 mil-
lion annually in the USA.2,3 CTS is typically diag-
nosed by history and physical examination, and elec-
trodiagnostic studies (nerve conduction studies and
sometimes electromyography) are used to confirm
the presence of a median mononeuropathy. Electro-
diagnostic studies have limitations; they are uncom-
fortable and do not directly assess the anatomy of
the median nerve and its surrounding structures.
Over the past 20 years, neuromuscular ultra-
sound has been introduced into electrodiagnostic
laboratories as a complement to nerve conduction
studies and electromyography for the diagnosis of
a variety of nerve and muscle conditions.4 CTS is
the condition most commonly studied with neuro-
muscular ultrasound, and individuals with CTS
have displayed ultrasonographic evidence of focal
enlargement of the median nerve at the wrist.5 In
addition, neuromuscular ultrasound can identify
causes of median mononeuropathy at the wrist
and structural anomalies that could not be
detected with electrodiagnostic studies alone, such
as compressive cysts, tumors, and vessels.5
This evidence-based guideline was designed to
address 2 critical questions regarding the use of
neuromuscular ultrasound for the diagnosis of
CTS. First, what is the accuracy of median nerve
cross-sectional area enlargement, as measured with
ultrasound, for the diagnosis of CTS? Second, what
added value, if any, does neuromuscular ultra-
sound provide over electrodiagnostic studies alone
for the diagnosis of CTS?
DESCRIPTION OF THE ANALYTIC PROCESS
The American Association of Neuromuscular and
Electrodiagnostic Medicine (AANEM) convened an
expert panel of physicians specializing in neurol-
ogy, physical medicine and rehabilitation, and radi-
ology, selected to represent a broad range of ex-
pertise related to neuromuscular ultrasound and
CTS. Some panel participants reported using
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neuromuscular ultrasound frequently for clinical
and research purposes, and others reported never
using the technology. All panel participants had
expertise in the clinical and electrodiagnostic
assessment of CTS.
In May 2011, PubMed was used to search Med-
line to identify all potential abstracts. The search
terms ‘‘carpal tunnel syndrome OR median nerve
OR median neuropathy’’ were combined with the
terms ‘‘ultrasound OR ultrasonography OR sono-
gram OR sonography.’’ This produced 724 articles
from 1990 to May 2011. This was narrowed to 641
articles by including ‘‘English-only’’ and ‘‘human-
only’’ studies. The titles of those articles were
reviewed for relevance, which yielded 240 articles,
and each abstract was then reviewed by at least 2
investigators. This resulted in 121 articles for full
manuscript review. After each article was reviewed
in its entirety by 2 investigators, 67 were identified
as relevant for this guideline. In order to be con-
sidered relevant, the article had to describe the
use of ultrasound to image the wrist in individuals
suspected of having CTS.
The 67 relevant articles were rated by at least 2
investigators according to criteria set by the Ameri-
can Academy of Neurology (AAN).6 Articles per-
taining to the accuracy of median nerve cross-sec-
tional area measurements for the diagnosis of CTS
(45 articles) were assessed using the AAN criteria
for rating an article on diagnostic accuracy, and
articles pertaining to neuromuscular ultrasound as
a screening tool to identify anatomic explanations
for CTS were assessed using AAN criteria for rating
a screening article (23 articles). One article was
assessed for both diagnostic accuracy and as a
screening article. Both rating systems are included
in the Appendices.
Studies with the highest levels of evidence
(Class I and II) are discussed in the text and sum-
marized in the evidence tables. At each step in the
process, disagreements were arbitrated by a third
investigator.
ANALYSIS OF THE EVIDENCE
Accuracy of Neuromuscular Ultrasound. Forty-five
relevant articles pertaining to the accuracy of neu-
romuscular ultrasound in the diagnosis of CTS
were identified. Four were graded as Class I and 2
as Class II. Of the 27 that were Class III, 18
received this rating because they had spectrum
bias (in all cases healthy volunteers served as the
control group); 6 received this rating because the
ultrasonographer was not blinded to clinical or
other diagnostic information; and 3 had both spec-
trum bias and lack of blinding.7–33 Spectrum bias
occurs when cases and controls are potentially at
opposite ends of the disease spectrum, which may
artificially enhance the diagnostic accuracy of a
test. For example, the articles with spectrum bias
reviewed in this study used healthy volunteers as
controls rather than a control population more
representative of individuals referred for possible
CTS in a typical clinical practice. If not explicitly
stated in the article that blinding of the ultraso-
nographer occurred, the corresponding author was
e-mailed to clarify this issue, and if no response
was received it was categorized as having not been
blinded. In general, the Class III articles demon-
strated high diagnostic accuracy of ultrasound for
the diagnosis of CTS, similar to the Class I and II
articles. Of the 12 articles graded as Class IV, 8
received this rating because they did not report
enough measures of diagnostic accuracy (sensitivity
and specificity, or a likelihood ratio) and 4
because the control group selection was not
acceptable.34–45 In all 4 cases in which the control
group selection was unacceptable, the control
group included individuals with symptoms consist-
ent with CTS but normal nerve conduction studies.
Although it is important to study individuals with
this type of conflicting clinical data (incongruent
symptoms and nerve conduction studies), it is the
authors’ opinion that it is problematic to use such
individuals as a control group when assessing the
accuracy of a diagnostic test.
Four articles were identified that met Class I
level of evidence (Table 1), meaning that the stud-
ies were prospective (cohort studies), were
blinded, were free of spectrum bias, used appropri-
ate reference standards, and included measures of
diagnostic accuracy.46–49 Three of the studies
defined individuals as having CTS if they had both
consistent clinical symptoms and abnormal nerve
conduction studies, whereas Altinok et al. defined
CTS as those with a consistent clinical presentation
and improvement in symptoms after 3 months of
non-surgical treatment. Three studies used wrists
contralateral to the wrist with CTS as the controls
(as long as the participant was asymptomatic on
that side and the nerve conduction studies were
normal on that side),46,47 and Altinok et al.
recruited controls from outpatients presenting to
the same clinic for causes unrelated to CTS. The
presence of different case definitions for CTS is
not problematic. In fact, in a condition such as
CTS, in which the ‘‘gold standard’’ for diagnosis is
debated, it is beneficial in evidence-based guide-
lines to have studies in which the reference stand-
ards for diagnosis were established using different
methods. Similarly, it is beneficial to have different
control groups, and the authors thought the 2 dif-
ferent control groups (contralateral unaffected
hands and individuals referred to the clinic for
non-CTS indications) were clinically appropriate
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and minimized spectrum bias. The use of contra-
lateral unaffected wrists also raised the question of
whether there was statistical independence
between the control wrists and the wrists with CTS.
This cannot be definitively answered without the
original data. However, if they were not independ-
ent, that would make the control and affected
wrists more similar, which would likely result in an
underestimation of the diagnostic accuracy of the
test.
The four Class I studies used slightly different
median nerve cross-sectional area cut-offs to diag-
nose CTS (ranging from 8.5 to 10 mm2), and all
studies used the direct tracing method to measure
median nerve area. Ziswiler et al. measured the
median nerve at the site of maximal enlargement
at the wrist, and the other 3 studies measured the
nerve at, or just proximal to, the level of the pisi-
form bone. Our guideline development panel con-
sidered studies with diagnostic accuracy >70% to
be acceptable and supportive of neuromuscular
ultrasound for the diagnosis of CTS (accuracy ¼
sensitivity  prevalence þ specificity  (1  preva-
lence)). The sensitivity of median nerve cross-sec-
tional area for the diagnosis of CTS ranged from
65% to 97%, specificity from 72.7% to 98%, and
accuracy from 79% to 97%. Interestingly, Altinok
et al. also analyzed their data using nerve conduc-
tion studies in addition to clinical diagnosis, and
this more strict case definition of CTS resulted in
an increase in the sensitivity of neuromuscular
ultrasound from 65% to 100%.
Two Class II articles were identified (Table 2),
and they met the same criteria as the Class I
articles, except they involved retrospective data col-
lection (case–control studies).50,51 Nakamichi and
Tachibana used only clinical criteria to classify par-
ticipants as CTS or controls, and the control sub-
jects were recruited from a health fair. The median
nerve cross-sectional area was calculated by tracing
the nerve at 3 sites within the carpal tunnel and
taking the mean of those measurements, with 12
mm2 selected as the cut-off for the diagnosis of
CTS. The study by Klauser et al. is unique among
the 6 Class I and II articles in that it only exam-
ined those with bifid median nerves within the car-
pal tunnel. The area of each portion of the nerve
was traced and then added together, and a single
cut-off of 12 mm2 was used. They also reported
improved accuracy when the difference between
the median nerve area measured at the wrist and
proximal forearm was calculated, with a difference
of 4 mm2 or greater used to diagnose CTS.
Conclusion. Based on consistent Class I and
Class II evidence, neuromuscular ultrasound mea-
surement of median nerve cross-sectional area at
the wrist is established as accurate for the diagnosis
of CTS.
Recommendation: If available, neuromuscular
ultrasound measurement of median nerve cross-
sectional area at the wrist may be offered as an
accurate diagnostic test for CTS (Level A).
Clinical Context. As is the case with all ultraso-
nographic imaging, neuromuscular ultrasound of
the median nerve at the wrist should be performed
and interpreted by clinicians experienced with the
technique. Scanning protocols and reference val-
ues for median nerve cross-sectional area at the
Table 1. Class I level of evidence studies* of the accuracy of neuromuscular ultrasound for the diagnosis of carpal tunnel syndrome.




without CTS Sensitivity Specificity Accuracy Area cut-off
2004 T. Altinok Clinical þ improvement
and NCS
40 40 65.0% 92.5% 78.9% 9 mm2
NA NA 100% 92.5% NA 9 mm2
2004 S.M. Wong Clinical þ NCS 64 33 82.8% 72.7% 79.3% 10 mm2
2005 H.-R. Ziswiler Clinical þ NCS 78 23 82.0% 87.0% 83.4% 10 mm2
2010 A. Mohammadi Clinical þ NCS 132 32 97.0% 98.0% 97.2% 8.5 mm2
NA, not available (data presented in the article did not include this value or permit calculation of this value); NCS, nerve conduction studies.
*To meet Class I level of evidence these studies are prospective, are blinded, are free of spectrum bias, have appropriate reference standards, and include
measures of diagnostic accuracy.







without CTS Sensitivity Specificity Accuracy Area cut-off
2002 K. Nakamichi Clinical 414 408 67.0% 97.0% 82.0% 12 mm2
2011† A.S. Klauser Clinical þ NCS 53 28 83.0% 50.0% 71.5% 12 mm2
92.5% 96.4% 93.9% D4 mm2‡
*To meet Class II level of evidence these studies are retrospective, are blinded, are free of spectrum bias, and include measures of diagnostic accuracy.
†This study only evaluated those with bifid median nerves.
‡This is the difference in median nerve area at the wrist compared to the forearm.
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wrist should be established by each laboratory
prior to using neuromuscular ultrasound for the
diagnosis of CTS.
Added Value of Neuromuscular Ultrasound. Twenty-
three articles were identified that potentially
demonstrated the added value of neuromuscular
ultrasound as a diagnostic tool when used in com-
bination with electrodiagnostic studies. Four were
graded as Class II (Table 3), and the rest were
classified as Class IV (all of these were case reports
and case series). None were graded as Class I,
because no studies drew from a population-based
sample of patients. None were Class III, because all
the studies that were not case reports or case series
met Class II criteria.
The 4 articles that met Class II criteria
described studies that drew from a statistical and
non-referral clinic-based sample of patients, eval-
uated all CTS patients prior to surgery, and
included neuromuscular ultrasound on all study
participants.7,52–54 Three of these articles described
the detection of bifid median nerves at the wrist,
and 2–13% of those with CTS had a bifid
nerve.7,53,54 Two studies described the detection of
persistent median arteries, which occurred in 9–
13% of those with CTS.7,54 The study by Padua
et al. also described the detection of tenosynovitis
(6%) and accessory muscles within the wrist (3%)
in those with CTS. The study by Nakamichi and
Tachibana was unique in that it assessed the
affected wrists in those with unilateral CTS (mean-
ing the contralateral side was normal by clinical
and nerve conduction criteria). Neuromuscular
ultrasound detected occult ganglia causing median
mononeuropathy in 25% of the CTS-affected wrists
in this population.
All 19 of the Class IV articles were case reports
or case series in which neuromuscular ultrasound
was used to identify abnormal structures causing
median mononeuropathy at the wrist. These struc-
tures included traumatic neuromas, Schwannomas,
lipofibromatous hamartomas, ganglion cysts,
thrombosed persistent median arteries, an abscess,
and compressive gouty tophus.55–73
Conclusion. Based on Class II evidence, neuro-
muscular ultrasound of the wrist probably adds
value to electrodiagnostic studies when assessing
CTS as it can detect structural abnormalities.
Recommendation: If available, neuromuscular
ultrasound should be considered to screen for
structural abnormalities at the wrist in those with
CTS (Level B).
Clinical Context. Screening for structural
abnormalities at the wrist that cause CTS is likely
to be of higher yield in those with atypical CTS.
This was demonstrated by Nakamichi and Tachi-
bana, who found a high rate of occult ganglia only
in those with unilateral CTS. This is an atypical
presentation, as most patients have bilateral CTS
(defined by symptoms, nerve conduction studies,
or both).52 Other atypical presentations of CTS
include sudden onset and onset in the setting of
trauma. Although ultrasound can identify struc-
tural abnormalities, it is possible these abnormal-
ities may not always be the underlying cause of the
median mononeuropathy. In addition, the preva-
lence of such abnormalities in the general popula-
tion is not known, so the sensitivity and specificity
of ultrasound for the identification of these struc-
tures cannot be calculated based on currently avail-
able data. The wide prevalence range for bifid me-
dian nerves (2–13%) may be secondary to
ultrasound device resolution (earlier studies identi-
fied fewer bifid nerves), ultrasound technique and
site of imaging within the wrist, or patient popula-
tion. The presence of structures such as persistent
median arteries and accessory muscles is clearly of
therapeutic interest, as it may alter the choice of
interventional approach (either injection or
Table 3. Class II level of evidence studies* of the added value of neuromuscular ultrasound in the diagnosis of carpal tunnel syndrome.
Year First author
Number
with CTS Percentage and type of abnormal structures
1993 K. Nakamichi 20 25% with unilateral CTS (by clinical and NCS criteria) have occult
ganglia in the carpal tunnel
2000 E. Iannicelli 294 2% with CTS have a bifid median nerve
2008 I.K. Bayrak 320 13% with CTS have a bifid median nerve
6% with CTS have a persistent median artery
2011 L. Padua 35 17% with CTS have a finding that changes therapeutic approach
9% have a bifid median nerve
9% have a persistent median artery
6% have tenosynovitis
3% have accessory muscles
*To meet Class II level of evidence these studies draw from a statistical and non-referral clinic-based sample of patients, evaluate all CTS patients prior to
surgery, and conduct neuromuscular ultrasound on all study participants.
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surgery). Knowledge of a bifid median nerve and
other anatomic variants is also of interest in plan-
ning the treatment of CTS,53 and identification of
such variants prior to invasive intervention can
even assist later in the assessment of failed inter-
vention. In addition, the presence of a bifid me-
dian nerve may be an independent risk factor for
the development of CTS.7
CLINICAL CONTEXT SUMMARY FOR ALL EVIDENCE
A single neuromuscular ultrasound evaluation of
the wrist in those with CTS allows for assessment of
both median nerve cross-sectional area and the
presence of structural abnormalities, and this com-
plements well the information obtained during an
electrodiagnostic study (which is the gold standard
for diagnosis of CTS). Some variability exists in the
devices, scanning protocols, and reference ranges
for the diagnosis of CTS when using neuromuscular
ultrasound, but this is to be expected. As a compari-
son, similar variability exists in electrodiagnostic
techniques. It is anticipated that with continued ex-
perience with neuromuscular ultrasound techni-
ques, more uniformity will occur as consensus devel-
ops regarding optimal use of the technology. It
should also be noted that many studies have pro-
posed other neuromuscular ultrasound parameters
that can be used to assist in the diagnosis of CTS,
but these were not assessed in this guideline. These
include median nerve flattening ratios; measures of
median nerve mobility, echogenicity, and vascular-
ity; and measures of flexor retinaculum bowing.
RECOMMENDATIONS FOR FUTURE RESEARCH
1 A standardized protocol for using neuromuscular
ultrasound in the diagnosis of CTS should be devel-
oped. This should include definition of the optimal
site of median nerve cross-sectional area measure-
ment, standardization of nerve outlining technique,
and further refinement of reference values.
2 Further research and evidence-based guidelines
should assess the usefulness of other neuromus-
cular ultrasound parameters for the diagnosis of
CTS, such as median nerve flattening, mobility,
echogenicity, vascularity, and bowing of the
flexor retinaculum.
3 Large population-based studies that enroll consec-
utive patients with CTS should be performed to
assess for all structural abnormalities that may be
causative or change therapeutic approach, which
will help further determine the added benefit of
neuromuscular ultrasound in the diagnosis of CTS.
4 Finally, large studies should be performed to
determine whether neuromuscular ultrasound
changes treatment strategies and outcomes in
those with CTS when compared with those in
which CTS is established using only electrodiag-
nostic studies. This type of study should also
allow for cost–benefit analyses of neuromuscular
ultrasound in the diagnosis of CTS.
DISCLAIMER
This statement has been provided as an educa-
tional service of the AANEM. It is based on an
assessment of current scientific and clinical infor-
mation. It is not intended to include all possible
proper methods of care of a particular neurologi-
cal problem or all legitimate criteria for choosing
to use a specific procedure. Neither is it intended
to exclude any reasonable alternative methodology.
The AANEM recognizes that specific patient care
decisions are the prerogative of the patient and
the physician caring for the patient, based on all
of the circumstances involved. The clinical context
section is made available in order to place the evi-
dence-based guidelines into perspective with cur-
rent practice habits and challenges. No formal
practice recommendation should be inferred.
The authors thank Gary Gronseth, MD, for his gracious assistance
and shared expertise regarding the grading of evidence, which was
critical for the creation of this evidence-based guideline.
APPENDIX 1: AAN CLASSIFICATION OF THE EVIDENCE
FOR RATING OF A DIAGNOSTIC ARTICLE6
Class I: A cohort study with prospective data collec-
tion of a broad spectrum of persons with the sus-
pected condition, using an acceptable reference
standard for case definition. The diagnostic test is
objective or performed and interpreted without
knowledge of the patient’s clinical status. Study results
allow calculation of measures of diagnostic accuracy.
Class II: A case–control study of a broad spec-
trum of persons with the condition established by
an acceptable reference standard compared with a
broad spectrum of controls, or a cohort study with
a broad spectrum of persons with the suspected
condition where the data were collected retrospec-
tively. The diagnostic test is objective or performed
and interpreted without knowledge of disease sta-
tus. Study results allow calculation of measures of
diagnostic accuracy.
Class III: A case–control study or cohort study
where either persons with the condition or con-
trols are of a narrow spectrum. The condition is
established by an acceptable reference standard.
The reference standard and diagnostic test are
objective or performed and interpreted by differ-
ent observers. Study results allow calculation of
measures of diagnostic accuracy.
Class IV: Studies not meeting Class I, II, or III
criteria, including consensus, expert opinion, or a
case report.
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APPENDIX 2: AAN CLASSIFICATION OF THE EVIDENCE
FOR RATING OF A SCREENING ARTICLE6
Class I: A statistical, population-based sample of
patients studied at a uniform point in time (usually
early) during the course of the condition. All
patients undergo the intervention of interest. The
outcome, if not objective, is determined in an eval-
uation that is masked to the patients’ clinical
presentations.
Class II: A statistical, non-referral clinic-based
sample of patients studied at a uniform point in
time (usually early) during the course of the condi-
tion. Most patients undergo the intervention of in-
terest. The outcome, if not objective, is deter-
mined in an evaluation that is masked to the
patients’ clinical presentations.
Class III: A sample of patients studied during
the course of the condition. Some patients
undergo the intervention of interest. The out-
come, if not objective, is determined in an evalua-
tion by someone other than the treating physician.
Class IV: Studies not meeting Class I, II, or III
criteria, including consensus, expert opinion, or a
case report.
APPENDIX 3: CLASSIFICATION OF
RECOMMENDATIONS
The four possible recommendation classifications
include:
• A ¼ Established as effective, ineffective or harm-
ful (or established as useful/predictive or not
useful/predictive) for the given condition in
specified population. (Level A rating requires at
least 2 consistent Class I studies.) [In exceptional
cases, 1 convincing Class I study may suffice for
an ‘‘A’’ recommendation if: (1) all criteria are
met; and (2) the magnitude of effect is large
(relative rate improved outcome >5 and the
lower limit of the confidence interval is >2.]
• B ¼ Probably effective, ineffective, or harmful
(or probably useful/predictive or not useful/pre-
dictive) for the given condition in the specified
population. (Level B rating requires at least 1
Class I study or 2 consistent Class II studies.)
• C ¼ Possibly effective, ineffective, or harmful (or
possibly useful/predictive or not useful/predic-
tive) for the given condition in the specified
population. (Level C rating requires at least 1
Class II study or 2 consistent Class III studies.)
• U ¼ Data inadequate or conflicting; given cur-
rent knowledge, treatment (test, predictor) is
unproven.
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